Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-16 Sale |
2021-12-20 5:59 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
200 | $20 | $4,001 | 10,936,041 (Indirect Direct) |
View |
| 2021-12-13 Sale |
2021-12-15 8:01 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100 | $20.02 | $2,002 | 10,936,241 (Indirect Direct) |
View |
| 2021-12-08 Sale |
2021-12-10 9:42 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
11,750 | $20.13 | $236,562 | 19,132,069 (Indirect Direct) |
View |
| 2021-12-07 Sale |
2021-12-09 9:52 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
19,792 | $20.48 | $405,433 | 8,348,091 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-12-16 Conversion |
2021-12-20 5:59 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
200 | $0 | 10,936,041 (Direct) |
View |
| 2021-12-13 Conversion |
2021-12-15 8:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100 | $0 | 10,936,241 (Direct) |
View |
| 2021-12-08 Exercise |
2021-12-10 9:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
28,646 | $2.47 | 19,132,069 (Direct) |
View |
| 2021-12-08 Exercise |
2021-12-10 9:42 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
28,646 | $0 | 19,132,069 (Direct) |
View |
| 2021-12-08 Conversion |
2021-12-10 9:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
6,574 | $0 | 19,132,069 (Direct) |
View |
| 2021-11-21 Gift |
2021-12-09 9:52 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
1,650,000 | $0 | 8,348,091 (Direct) |
View |
| 2021-04-20 Other |
2021-04-22 7:57 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
9,467,883 | $0 | 29,903,649 (Direct) |
View |
| 2021-04-20 Conversion |
2021-04-22 7:57 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
3,110,766 | $0 | 29,903,649 (Direct) |
View |
Ownership |
2021-04-15 08:57 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer 10% Owner |
0 | $0 | 10,967,883 (Direct) |
View |